The drugmaker stopped paying 340B discounts to hospitals that didn’t comply with its new paperwork requirements late last ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

On May 28, representatives from three states introduced a federal bill to amend the 340B program by recognizing contract pharmacies, restricting pharmacy benefit managers and tightening eligibility ...

The results indicate that the program could play a role in discouraging use of biosimilars in the United States. Hospitals participating in the 340B Drug Pricing Program had lower biosimilar uptake, ...

The 340B drug discount program would work better if the money followed the patient rather than going directly to hospitals, Anthony DiGiorgio, DO, MHA, said Monday at an event on 340B sponsored by the ...

Throughout 2022, the 340B Drug Program (340B) and participating hospital systems experienced myriad new developments. From continued disputes with drug manufacturers to a landmark U.S. Supreme Court ...

Long-term 340B participation is linked to stronger financial assets, with much of the program’s recent growth flowing ...

In this podcast, Jason Reddish, Principal and Mark Ogunsusi, Associate, at Powers Pyles Sutter & Verville provide an overview of the program and the compliance requirements. They are also two of the ...

Though it used the majority of its public comment letter making the case against drug manufacturer-preferred rebates for 340B drugs, the American Hospital Association also outlined "bare minimum ...

When the 340B drug pricing program was established in 1992, Congress intended for the program to help low-income and uninsured patients with their prescription drugs. The pharmaceutical companies ...

Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...

Policies written with the best intentions can be misinterpreted or misused. This is especially true if proper oversight is lacking or if new policy creates unforeseen opportunities. I believe this is ...